460 related articles for article (PubMed ID: 30592755)
1. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
2. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive glycome profiling of Huntington's disease transgenic mice.
Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S
Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
5. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
[TBL] [Abstract][Full Text] [Related]
6. Serum N-Glycome analysis reveals pancreatic cancer disease signatures.
Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM
Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301
[TBL] [Abstract][Full Text] [Related]
7. Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS.
Qin W; Zhang Z; Qin R; Han J; Zhao R; Gu Y; Pan Y; Gu J; Ren S
Anal Chim Acta; 2019 Nov; 1081():112-119. PubMed ID: 31446948
[TBL] [Abstract][Full Text] [Related]
8. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
10. High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis.
Uematsu R; Furukawa J; Nakagawa H; Shinohara Y; Deguchi K; Monde K; Nishimura S
Mol Cell Proteomics; 2005 Dec; 4(12):1977-89. PubMed ID: 16170054
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.
Kamiyama T; Yokoo H; Furukawa J; Kurogochi M; Togashi T; Miura N; Nakanishi K; Kamachi H; Kakisaka T; Tsuruga Y; Fujiyoshi M; Taketomi A; Nishimura S; Todo S
Hepatology; 2013 Jun; 57(6):2314-25. PubMed ID: 23322672
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
13. Differential
Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
[TBL] [Abstract][Full Text] [Related]
14. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
15. Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry.
Amano M; Nishimura S
Methods Enzymol; 2010; 478():109-25. PubMed ID: 20816476
[TBL] [Abstract][Full Text] [Related]
16. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
17. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M
World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
19. Tear N-glycomics in vernal and atopic keratoconjunctivitis.
Messina A; Palmigiano A; Tosto C; Romeo DA; Sturiale L; Garozzo D; Leonardi A
Allergy; 2021 Aug; 76(8):2500-2509. PubMed ID: 33583051
[TBL] [Abstract][Full Text] [Related]
20. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
